Order Article Reprints

Chantasrisawad N, Puthanakit T, Tangsathapornpong A, Techasaensiri C, Phongsamart W, Suwanpakdee D, Jaruampornpan P, Sophonphan J, Suntarattiwong P, Chotpitayasunondh T on behalf of the Study Team. Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases. Vaccines. 2022; 10(6):871. https://doi.org/10.3390/vaccines10060871

Chantasrisawad, Napaporn, Thanyawee Puthanakit, Auchara Tangsathapornpong, Chonnamet Techasaensiri, Wanatpreeya Phongsamart, Detchvijitr Suwanpakdee, Peera Jaruampornpan, Jiratchaya Sophonphan, Piyarat Suntarattiwong, and Tawee Chotpitayasunondh on behalf of the Study Team. 2022. "Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases" Vaccines 10, no. 6: 871. https://doi.org/10.3390/vaccines10060871

Chantasrisawad, N., Puthanakit, T., Tangsathapornpong, A., Techasaensiri, C., Phongsamart, W., Suwanpakdee, D., Jaruampornpan, P., Sophonphan, J., Suntarattiwong, P., & Chotpitayasunondh, T., on behalf of the Study Team. (2022). Immunogenicity and Reactogenicity of mRNA BNT162b2 COVID-19 Vaccine among Thai Adolescents with Chronic Diseases. Vaccines, 10(6), 871. https://doi.org/10.3390/vaccines10060871